Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 26, 2017
Pharmacy Choice - News - Front Page Healthcare News - May 26, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/19/17 - "Expandable Endoscopic Hoods and Related Methods of Use" in Patent Application Approval Process (USPTO 20170112359)
By a News Reporter-Staff News Editor at Health& Medicine Week A patent application by the inventors RAYBIN, Samuel; CHENG, Ruth; SMITH, Paul; SUON, Naroun, filed on October 14, 2016, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigne
5/19/17 - "Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use" in Patent Application Approval Process (USPTO 20170112821)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Horn, Gerald, filed on January 9, 2017, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution. Due to the incr
5/19/17 - "Pharmaceutical Compositions Comprising Gels and Methods for Fabricating Thereof" in Patent Application Approval Process (USPTO 20170112936)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Karolchyk, John Scott; Saadeh, Dennis Elias, filed on January 5, 2017, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company
5/19/17 - "Therapeutic Combinations of Sesquiterpenes and Flavonoids" in Patent Application Approval Process (USPTO 20170112802)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Yamaguchi, Masayoshi, filed on October 14, 2016, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Primus Pharmaceuticals, Inc.. Baicalin and
5/19/17 - "Timed, Pulsatile Release Systems" in Patent Application Approval Process (USPTO 20170112774)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Venkatesh, Gopi M., filed on January 9, 2017, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Adare Pharmaceuticals, Inc.. The following qu
5/19/17 - A couple with cancer together can stay together
Steve and Vali Welhoelter are a retired couple who live two blocks from the beach in Ponce Inlet. Diagnosed with an aggressive brain cancer, glioblastoma multiforme, Mr. Welhoelter wears a relatively new device called Optune every day. Mr. Welhoelter said that, untreated, life expectancy for someone with GBM is six months.
5/19/17 - A strong EU IP framework guarantees future innovation for patients
Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients' lives; and reducing overall costs for healthcare systems. With over 80 medicines approved every year - including some 30 new, approv
5/19/17 - A.M. Best Briefing: Impact of American Health Care Act Positive for Carriers Participating in Individual Markets
A.M. Best thinks some provisions within the American Health Care Act hold the potential to aid health insurance companies in alleviating the profitability issues associated with the current individual markets. Some of the AHCA provisions that A.M. Best believes would be positive for health insurance carriers include:. A.M. Best believes some AHCA f
5/19/17 - AAP Responds to FDA Reauthorization Act of 2017 as Passed by House Subcommittee
The American Academy of Pediatrics issued the following news release:. The FDA Reauthorization Act of 2017 passed today by the U.S. House of Representatives Energy and Commerce Health Subcommittee to reauthorize U.S. Food and Drug Administration user fees is a missed opportunity for children. The House vote comes one week after the U.S. Senate Comm
5/19/17 - Abeona Therapeutics to Present at Multiple Upcoming Conferences
ABO-102 gene therapy program for Sanfilippo syndrome Type A: Abeona announced top-line data for Phase 1/ 2 MPS IIIA gene therapy trial at ASGCT Positive dose response in central nervous system with 60.7%+/- 8.8% reduction of disease-causing heparan sulfate GAG observed in Cohort 2 Reduction of disease manifestation observed in decreased liver v
5/19/17 - Acute Market Reports: 2017 Global market Demand Generic Drug Market - Global Industry Analysis, Market Size, Share, Growth, Trend, Market Capacity, Production, Revenue, Price and Gross Margin and Forecast 2022 by QY Research Reports
The United States Generic Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Generic Drug industry. The Generic Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. The report focuses on
5/19/17 - Acute Market Reports: New Market Research Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trend, Market Capacity, Production, Revenue, Price and Gross Margin and Forecast 2022 by QY Research Reports
This report studies Vaccines in Global and China market, focuses on top manufacturers in global and China market, involving Vaccines price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Vaccines in USA, EU, China, Japan, India and Southeast Asia, foreca
5/19/17 - Agios to Present Updated Clinical Data from PKR Activator AG-348 at EHA [T-break Tech (Middle East)]
-Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic diseases, today announced that updated clinical data from the fully enrolled, ongoing Phase 2 study of AG-348 in adults with pyruvate kinase deficiency, a rare, potentially debilitating, congenital anemia, will be presented at the 22nd Congress of the Europea
5/19/17 - Albireo Unveils Plans for Phase 3 Clinical Program [Tehran Times (Iran)]
Albireo Pharma, Inc. was out Thursday with key study design details for a planned phase 3 program of lead product candidate, A4250, in patients with progressive familial intrahepatic cholestasis determined following consultations with the U.S. Food and Drug Administration and European Medicines Agency. PFIC is a rare and life-threatening genetic li
5/19/17 - Ambulatory services market to reach $3.7 Trillion by 2024 Ameri Research Inc.
Ambulatory Services Market Outlook To 2024: Key Service Categories, Regional Segmentation, Competitive Dynamics, Pricing Analysis And Segment Forecast 19 th April 2017, Florida- The global ambulatory services market size worth USD 3.7 trillion by 2024, according to a new research study published by Ameri Research. The U.S. spends nearly 3.2 trillio
5/19/17 - AMCP Joins 10 Organizations in Joint Comment Letter to the FDA on Draft Interchangeability Guidance
All of the undersigned groups share the FDA's deep commitment to the development of a robust biosimilars market for patients, and greatly appreciate all the work the agency has done in creating certainty around the approval pathway created by the Biologics Price Competition and Innovation Act, including the long anticipated proposed guidance detail
5/19/17 - AMERICA TAKES STEP AWAY FROM COMPASSION
It is a guarantee that millions of Americans woke up last Friday embracing the fact that Obamacare is one step closer to the grave. And equally certain that many of these same people do not fully understand that so are they. No matter the facts of this intended legislation- its massive reduction in Medicaid monies and government subsidies, its demo
5/19/17 - Amicus Therapeutics Announces Planned Analysis of Primary Endpoints in Phase 3 Epidermolysis Bullosa Study
Amicus Therapeutics, Inc., has completed the analysis plan for the primary endpoints in the blinded ongoing Phase 3 clinical study of the novel topical medicine SD-101 for epidermolysis bullosa. Time to Wound Closure is as an acceptable efficacy endpoint for wound-related diseases, per FDA guidance. 1. Jay Barth, MD, Chief Medical Officer of Amic
5/19/17 - Atossa Genetics Completes Enrollment for Trial
Atossa Genetics announced it completed enrollment for a Phase 1 study of Endoxifen. Endoxifen is an active metabolite of the FDA- approved drug tamoxifen, which is used to treat breast cancer and for breast cancer prevention in high risk patients. The post Atossa Genetics Completes Enrollment for Trial appeared first on Investing News Network.
5/19/17 - Atossa Genetics Completes Enrollment in Topical Arm of Endoxifen Phase 1 Study
Atossa Genetics, Inc., a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced that it completed enrollment in the topical arm of its Phase 1 dose escalation study of Atossa's proprietary Endoxifen. The study is being conducted on behalf of Atossa by C
5/19/17 - Avenue Therapeutics Receives Notice of Allowance for a New Patent Application Covering Methods of Administration for Intravenous Tramadol
Avenue Therapeutics, Inc., a Fortress Biotech Company, today announced that Notice of Allowance has now been received from the U.S. Patent and Trademark Office for a new patent application, entitled " Intravenous Administration of Tramadol. The patent application describes and claims a dosing regimen of intravenous 50 mg tramadol that provides
5/19/17 - AVEO Oncology Announces Completion of a CHMP Oral Explanation for Tivozanib as a Treatment of First-Line Renal Cell Carcinoma
AVEO Oncology today announced its European licensee for tivozanib, EUSA Pharma, has completed an oral explanation to the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, as part of the Marketing Authorization Application review process for tivozanib as a treatment for patients with first-lin
5/19/17 - Bayer receives FDA priority review for copanlisib to treat follicular lymphoma [Syrian Arab News Agency]
German drug manufacturer Bayer has received priority review designation for the new drug application for copanlisib from the US Food and Drug Administration. Bayer Pharmaceuticals America region head Carsten Brunn said: With this milestone, we are one step closer to making copanlisib available in the US to the community of doctors and patients faci
5/19/17 - Biogen Buys Remedy Pharma` Late-Stage Drug CIRARA [Syrian Arab News Agency]
Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to people affected by central nervous system diseases and injuries, announced that Biogen completed an asset purchase of its Phase 3 candidate, CIRARA. The U.S. Food and Drug Administration recently granted CIRARA Orphan drug designation for..
5/19/17 - Bipartisan Plan Aims to Make Hospitals Safer, Help RNs Provide the Best Care Possible
The Michigan Nurses Association issued the following news:. "Your nurse is your first line of defense in the hospital, but RNs all over the state report that they have less and less time to spend monitoring and taking care of each patient," said John Armelagos, RN, president of the Michigan Nurses Association. The strong bipartisan support for the
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415